Zydus Lifesciences share price extended the gains on second day, rising 1 percent in the early trade on April 15 following United States Food and Drug Administration (USFDA) approval for Jaythari ...

Zydus Lifesciences Ltd (NSE: ZYDUSLIFE) on Friday, April 11, announced that it has received final approval from the United ...

Zydus Lifesciences has secured final approval from the US Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) tablets in four strengths - 6 mg, 18 mg, 30 mg, and 36 mg.

The drugmaker has received the USFDA's final approval to manufacture a particular corticosteroid called Deflazacort to treat Duchenne muscular dystrophy.

Zydus Lifesciences has received final approval from the United States Food and Drug Administration (USFDA) to manufacture Jaythari (Deflazacort) Tablets, 6 mg, 18 mg, 30 mg, and 36 mg (USRLD: Emflaza ...

Ahmedabad: Pharma major, Zydus Lifesciences Limited has received final approval from the United States Food and Drug ...

Stocks like NCL Industries, Persistent Systems, Repco Home Finance, JK Cement, Canara Bank, Union Bank of India, and Yatra ...

Find all the commercial and brand names of generic drug called Deflazacort. This is an invaluable reference resource for healthcare professionals, patients, caregivers and anyone in need of ...